TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed December 12, 1975
